Neumora Secures $500M, Amgen Deal, in Quest for Precision Neuroscience R&D

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Neumora Snaps Up $112M to Advance Precision Neuroscience Work Through Clinic
Pretzel Gets $72.5M for Gene Editing & Small Molecules Against Mitochondrial Targets
Arch Bets $50M on Vilya, Baker Lab Spinout to Make Targeted, Oral Peptide Drugs
Investing in Manufacturing, Mental Health & More: Bob Nelsen on The Long Run